Resveratrol-based Nutraceuticals for the Management of Diabetes and Obesity: Real Therapeutic Potential or a mere Palliative?

Giuseppe Annunziata*, Gian Carlo Tenore and Ettore Novellino

Received: June 12, 2018;   Published: June 19, 2018

DOI: 10.32474/ADO.2018.01.000109

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

It is well known that obesity and diabetes (more specifically, the type 2 diabetes mellitus, T2DM) are currently a growing public health problem, which involves several millions subjects in the World. Years ago, indeed, the term “diabesity” was coined highlighting not only the strong pathogenic relationship between obesity and T2DM, but also the pandemic aspect that link these two diseases. The increasing global prevalence of diabesity represents a grave concern in terms of public health and, at the same time, medical costs, resulting in a serious social economic issue.

Editorial| References|